Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

COVID-19 infection can significantly cause temporary hair loss.

Dermoscopy is effective for diagnosing various skin infestations and infections.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Cannabidiol shows promise as an effective treatment for acne.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Retinol may affect immune responses in people with frequent skin boils.

Minoxidil in breast milk may harm nursing infants.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Some alternative therapies for vitiligo show promise but need more research.

Camellia japonica extract may improve scalp health and promote hair growth.

Drugs can change hair growth and this is important because it can upset people.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.

Hair loss can be an early sign of HIV infection.